,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
23,regulation of transcription by RNA polymerase II (GO:0006357),0.4295212332549316,1.257299727519624,0.001,0.7204717794469647,1.0,187/433,37.01%,ZBTB20;TCF4;RUNX1;NFIX;ZEB1;TCF12;ZEB2;NCOA1;PAX7;ATRX;NIPBL;TEAD1;NCOR1;ARID5B;FOXP1;JMJD1C;PHF21A;NFIB;MAML3;PBX1;WWOX;CUX1;RREB1;MEF2A;STAT3;ATXN1;BBX;ZFHX4;PEG3;TCF7L2;ZFHX3;DDX5;TRPS1;PURB;ARID1B;DDX17;CHD4;CDK8;KMT2C;CNOT1;CHD2;ARID4B;MEIS2;HDAC4;CREBBP;TSHZ3;BCAS3;WWTR1;TET2;ZHX3;OGT;APP;TBL1X;FOXO1;NFAT5;MLLT10;SREBF2;RLF;SOX4;DCAF6;ZBTB7C;BRD4;KDM5B;NSD1;BPTF;CBX5;MTDH;ATAD2B;THRA;NR6A1;HDAC8;SFPQ;RFX3;MAML2;TPR;KMT2A;SIX1;ZHX2;GATAD2B;NCOA2;KAT6B;HNRNPU;ASXL2;NFKB1;CREB5;PIAS2;FUS;ARNT;TCF25;NFIC;HIVEP2;PHF20;KDM2A;ZMIZ1;PRRX1;RB1;HIPK2;MED13L;KDM3A;KLF3;TCF7L1;RSF1;LRRFIP1;NR3C1;BRD7;MED13;HOXC4;RFX7;KDM1A;NOTCH1;HOXC5;STAT5B;KDM4C;TBL1XR1;KDM7A;N4BP2L2;MECP2;BCLAF1;HOXC6;CLOCK;RCOR1;KLF7;POU2F1;PKNOX2;SMARCC1;RBPJ;HIF1A;PIAS1;EZH1;NR2C2;ENO1;KAT2B;SBNO2;THRAP3;MIER1;TCF20;PRDM2;FOXO3;LCOR;KDM6B;GLIS2;ATF6;KDM3B;AUTS2;ESR1;CREB3L2;CHD8;BCL9L;TET3;RUNX2;EPC1;NCOR2;ASXL1;MRTFB;BRD3;EP300;IKZF2;SMARCA5;NRIP1;ZBTB38;CREBRF;SKI;IRF2;PURA;MRTFA;ETV6;TRIM33;MXI1;JUN;ATF2;RAD21;EGFR;CCNT2;MEIS1;SMAD3;SIRT2;CHD3;DHX36;ARID4A;NCOA6;SMARCC2;CREB1;TFDP2;GLYR1;ARID1A;MGA;KAT6A
0,nervous system development (GO:0007399),0.6753171282342175,1.735531587979593,0.0010080645161290322,0.11996661626052538,0.089,12/26,12.50%,RBFOX2;NAV1;ZEB2;TEAD1;STAT3;ATXN1;MBD5;JARID2;HDAC4;WWTR1;CHD7;SREBF2
1,central nervous system development (GO:0007417),0.6637859167225122,1.661601050511657,0.002028397565922921,0.17490931026219456,0.225,11/21,13.97%,NIPBL;NFIB;PBX1;STAT3;ATXN1;ZFHX3;JARID2;MEIS2;CHD7;SOX4;BPTF
21,positive regulation of transcription by RNA polymerase II (GO:0045944),0.43945353287564637,1.2771641635928612,0.004,0.6889603038491211,1.0,111/224,37.38%,TCF4;RUNX1;NFIX;TCF12;ZEB2;NCOA1;ATRX;TEAD1;NFIB;MAML3;PBX1;WWOX;RREB1;MEF2A;STAT3;PEG3;TCF7L2;ZFHX3;DDX17;CDK8;KMT2C;MEIS2;HDAC4;CREBBP;BCAS3;WWTR1;TET2;OGT;APP;TBL1X;FOXO1;NFAT5;MLLT10;SREBF2;RLF;SOX4;DCAF6;BRD4;BPTF;ATAD2B;THRA;HDAC8;SFPQ;RFX3;MAML2;KMT2A;SIX1;NCOA2;KAT6B;HNRNPU;ASXL2;NFKB1;ARNT;NFIC;ZMIZ1;HIPK2;RSF1;NR3C1;MED13;HOXC4;KDM1A;NOTCH1;STAT5B;TBL1XR1;BCLAF1;CLOCK;KLF7;POU2F1;RBPJ;HIF1A;NR2C2;KAT2B;SBNO2;THRAP3;TCF20;PRDM2;FOXO3;KDM6B;GLIS2;ATF6;AUTS2;ESR1;CHD8;BCL9L;TET3;RUNX2;EPC1;ASXL1;MRTFB;EP300;SMARCA5;NRIP1;ZBTB38;CREBRF;SKI;IRF2;MRTFA;JUN;ATF2;EGFR;CCNT2;MEIS1;SMAD3;SIRT2;DHX36;NCOA6;CREB1;TFDP2;GLYR1;KAT6A;CCNT1
26,"regulation of transcription, DNA-templated (GO:0006355)",0.4274766452100134,1.2442827320541245,0.005,0.6938872071539383,1.0,182/425,37.01%,ZBTB20;TCF4;RUNX1;NFIX;ZEB1;TCF12;RBFOX2;ZEB2;FOXN3;NCOA1;PAX7;ATRX;NIPBL;SETD5;KMT2E;TEAD1;NCOR1;ARID5B;FOXP1;JMJD1C;NFIB;PBX1;CUX1;RREB1;MEF2A;STAT3;ATXN1;BBX;ZFHX4;PEG3;TCF7L2;ZFHX3;DDX5;JARID2;TRPS1;PURB;ARID1B;DDX17;CHD4;CHD2;ARID4B;MEIS2;HDAC4;CREBBP;TSHZ3;WWTR1;NSD3;ZHX3;OGT;CHD7;TBL1X;FOXO1;NFAT5;SREBF2;RLF;SOX4;ZBTB7C;BRD4;UIMC1;MBTD1;KDM5B;NSD1;BPTF;CBX5;MTDH;KDM5A;THRA;NR6A1;SFPQ;RFX3;MLLT3;KMT2A;SIX1;ZHX2;NCOA2;KAT6B;HMG20A;CDK17;NFKB1;CREB5;PIAS2;FUS;ARNT;DYRK1A;NFIC;HIVEP2;PHF20;KDM2A;ZMIZ1;PRRX1;RB1;HIPK2;MED13L;KDM3A;PBXIP1;ZMYND11;KLF3;TCF7L1;RSF1;LRRFIP1;NR3C1;BRD7;MED13;HOXC4;RFX7;KDM1A;NOTCH1;WAC;HOXC5;STAT5B;KDM4C;TBL1XR1;KDM7A;CCAR1;MECP2;BCLAF1;HOXC6;CLOCK;SCMH1;RCOR1;KLF7;POU2F1;PKNOX2;BAZ2A;SMARCC1;RBPJ;HIF1A;PIAS1;NR2C2;ENO1;SBNO2;THRAP3;KDM5C;EHMT1;TCF20;PRDM2;FOXO3;SBNO1;BICRAL;LCOR;GLIS2;ATF6;KDM3B;ESR1;CREB3L2;CHD8;PHC3;RUNX2;EPC1;NCOR2;BRD3;EP300;IKZF2;SMARCA5;ZBTB38;HP1BP3;CREBRF;IRF2;PURA;BICRA;CBFA2T2;ETV6;TRIM33;MXI1;JUN;ATF2;RAD21;EGFR;CCNT2;MEIS1;SMAD3;SIRT2;CHD3;DHX36;ARID4A;NCOA6;SMARCC2;CREB1;TFDP2;ARID1A;MGA;KAT6A
25,"positive regulation of transcription, DNA-templated (GO:0045893)",0.4277145328380312,1.248123433961607,0.005,0.7034370886226411,1.0,127/271,37.01%,TCF4;RUNX1;NFIX;TCF12;ZEB2;NCOA1;ATRX;KMT2E;TEAD1;NFIB;MAML3;PBX1;WWOX;RREB1;MEF2A;STAT3;PEG3;TCF7L2;ZFHX3;ARID1B;DDX17;CDK8;KMT2C;MEIS2;HDAC4;CREBBP;BCAS3;WWTR1;NSD3;TET2;OGT;APP;TBL1X;FOXO1;NFAT5;MLLT10;SREBF2;RLF;SOX4;DCAF6;BRD4;NSD1;BPTF;KDM5A;ATAD2B;THRA;HDAC8;SFPQ;RFX3;MLLT3;MAML2;KMT2A;SIX1;NCOA2;KAT6B;HNRNPU;ASXL2;NFKB1;CREB5;ARNT;DYRK1A;NFIC;ZMIZ1;HIPK2;KDM3A;RSF1;NR3C1;BRD7;MED13;HOXC4;KDM1A;NOTCH1;WAC;STAT5B;TBL1XR1;BCLAF1;CLOCK;KLF7;POU2F1;SMARCC1;RBPJ;HIF1A;NR2C2;KAT2B;SBNO2;THRAP3;TCF20;PRDM2;FOXO3;BICRAL;KDM6B;GLIS2;ATF6;AUTS2;ESR1;CREB3L2;CHD8;BCL9L;TET3;RUNX2;EPC1;ASXL1;MRTFB;EP300;SMARCA5;NRIP1;ZBTB38;CREBRF;SKI;IRF2;BICRA;MRTFA;JUN;ATF2;EGFR;CCNT2;MEIS1;SMAD3;SIRT2;DHX36;NCOA6;SMARCC2;CREB1;TFDP2;GLYR1;ARID1A;KAT6A
2,regulation of cell differentiation (GO:0045595),0.636131605454647,1.6266878214859546,0.00508646998982706,0.1794458629779287,0.332,7/20,9.93%,RUNX1;ZFHX3;DDX5;TRPS1;PURB;DDX17;CREBBP
4,histone lysine demethylation (GO:0070076),0.6432824330329252,1.5512468989716288,0.011446409989594173,0.2675557979457432,0.625,12/16,28.80%,JMJD1C;KDM5B;KDM5A;KDM6A;KDM2A;KDM3A;KDM1A;KDM4C;KDM7A;KDM5C;KDM6B;KDM3B
3,positive regulation of cellular catabolic process (GO:0031331),0.6506133866146816,1.5705676265426884,0.018518518518518517,0.266900518109026,0.532,10/15,28.68%,ZBTB20;GSK3B;CNOT1;APP;FOXO1;MTDH;ARNT;HIF1A;FOXO3;ATF6
31,"negative regulation of transcription, DNA-templated (GO:0045892)",0.41613334523436263,1.2152271441915816,0.021,0.6980620491335927,1.0,106/235,36.40%,RUNX1;NFIX;ZEB1;RBFOX2;ZEB2;FOXN3;NIPBL;NCOR1;ARID5B;FOXP1;PHF21A;WWOX;CUX1;RREB1;MEF2A;STAT3;ATXN1;PEG3;TCF7L2;ZFHX3;DDX5;JARID2;TRPS1;CNOT1;MEIS2;HDAC4;CREBBP;TSHZ3;ZHX3;TBL1X;FOXO1;SREBF2;UIMC1;MBTD1;NSD1;BPTF;CBX5;MTDH;THRA;NR6A1;HDAC8;SFPQ;RFX3;TPR;ZHX2;GATAD2B;KAT6B;HNRNPU;NFKB1;TCF25;NFIC;KDM2A;RB1;PBXIP1;ZMYND11;RSF1;LRRFIP1;NR3C1;BRD7;KDM1A;NOTCH1;TBL1XR1;N4BP2L2;MECP2;BCLAF1;CLOCK;SCMH1;RCOR1;KLF7;POU2F1;RBPJ;EZH1;NR2C2;ENO1;SBNO2;KDM5C;MIER1;EHMT1;PRDM2;FOXO3;LCOR;GLIS2;ESR1;CHD8;PHC3;RUNX2;EPC1;NCOR2;EP300;NRIP1;ZBTB38;SKI;IRF2;PURA;CBFA2T2;ETV6;TRIM33;MXI1;JUN;SMAD3;SIRT2;CHD3;ARID4A;SMARCC2;CREB1;TFDP2
5,regulation of myeloid cell differentiation (GO:0045637),0.6123063298694822,1.5161171068316917,0.023760330578512397,0.3278079388295308,0.755,6/17,9.93%,RUNX1;KMT2E;PURB;KMT2C;MEIS2;CREBBP
29,negative regulation of transcription by RNA polymerase II (GO:0000122),0.4210903629903672,1.2236564206683507,0.034,0.708407909632531,1.0,77/175,35.17%,RUNX1;NFIX;ZEB1;ZEB2;ATRX;NIPBL;NCOR1;ARID5B;FOXP1;PHF21A;NFIB;WWOX;CUX1;RREB1;MEF2A;STAT3;ATXN1;PEG3;TCF7L2;ZFHX3;DDX5;TRPS1;CNOT1;MEIS2;HDAC4;CREBBP;TBL1X;SREBF2;NSD1;BPTF;CBX5;MTDH;THRA;NR6A1;HDAC8;SFPQ;TPR;ZHX2;GATAD2B;HNRNPU;NFKB1;TCF25;NFIC;RB1;LRRFIP1;NR3C1;KDM1A;NOTCH1;TBL1XR1;N4BP2L2;MECP2;KLF7;RBPJ;EZH1;NR2C2;ENO1;MIER1;PRDM2;FOXO3;LCOR;GLIS2;ESR1;CHD8;EPC1;NCOR2;EP300;NRIP1;SKI;IRF2;PURA;ETV6;TRIM33;MXI1;JUN;SMAD3;SIRT2;CHD3
6,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.6013693303355014,1.4600552970937757,0.05439330543933055,0.5095340796275376,0.902,6/16,11.76%,RBFOX2;STAT3;WASF2;GSK3B;ACTB;FOXO1
9,negative regulation of Wnt signaling pathway (GO:0030178),0.5574555634213892,1.395622094036945,0.054414784394250515,0.6280605204227505,0.982,6/18,15.81%,WWOX;TCF7L2;PSME4;GSK3B;WWTR1;MLLT3
8,regulation of signal transduction (GO:0009966),0.5756717590247846,1.4008314749927933,0.05527123848515865,0.6708497336921443,0.976,6/17,12.50%,RUNX1;CREBBP;WWTR1;OGT;APP;SREBF2
7,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.5884144114111016,1.4178562055621393,0.05753138075313807,0.6543977292446516,0.957,10/15,29.78%,RBFOX2;RBM39;DDX5;DDX17;FAM172A;HNRNPU;NCL;THRAP3;SRPK2;YTHDC1
10,regulation of primary metabolic process (GO:0080090),0.5408761231411936,1.3806336564377357,0.07222787385554426,0.6433656578677526,0.99,8/21,16.91%,NCOA1;NCOR1;CHD9;PSME4;CREBBP;TBL1X;SREBF2;NCOA2
12,cellular response to cytokine stimulus (GO:0071345),0.5175378434003329,1.3418991457920377,0.0755287009063444,0.7319747193814474,0.998,14/29,27.57%,ZEB1;STAT3;GSK3B;FOXO1;NFAT5;TPR;HNRNPU;NFKB1;PIK3CA;STAT5B;POU2F1;HIF1A;SBNO2;FOXO3
13,positive regulation of signal transduction (GO:0009967),0.5254314464000911,1.3406373603092885,0.07692307692307693,0.6868196794074976,0.999,15/24,32.48%,MAML3;STAT3;MBD5;CREBBP;MAML2;ASXL2;ARNT;ZMIZ1;NOTCH1;RBPJ;HIF1A;KAT2B;ASXL1;EP300;SKI
14,regulation of canonical Wnt signaling pathway (GO:0060828),0.506366407597137,1.324234590908164,0.08796764408493428,0.7248403116917458,0.999,9/26,17.89%,ZEB2;TCF7L2;PSME4;GSK3B;WWTR1;TBL1X;SOX4;MLLT3;NFKB1
11,RNA processing (GO:0006396),0.5725969394328603,1.3692682342636597,0.09345794392523364,0.6448625675180621,0.996,7/15,18.50%,RBM39;ATXN1;DDX17;SFPQ;SF3B1;HNRNPU;FUS
36,positive regulation of nucleic acid-templated transcription (GO:1903508),0.4078363739556895,1.1673407081083402,0.108,0.7914854044406091,1.0,59/126,37.01%,TCF4;RUNX1;NCOA1;KMT2E;TEAD1;NFIB;RREB1;STAT3;ZFHX3;ARID1B;HDAC4;CREBBP;NSD3;TBL1X;FOXO1;RLF;SOX4;BRD4;NSD1;KDM5A;RFX3;MLLT3;KMT2A;SIX1;KAT6B;NFKB1;CREB5;DYRK1A;ZMIZ1;HIPK2;KDM3A;RSF1;BRD7;MED13;NOTCH1;WAC;TBL1XR1;CLOCK;SMARCC1;HIF1A;THRAP3;FOXO3;BICRAL;GLIS2;ESR1;CREB3L2;CHD8;RUNX2;EPC1;EP300;BICRA;JUN;EGFR;SMAD3;NCOA6;SMARCC2;CREB1;ARID1A;KAT6A
16,regulation of lipid metabolic process (GO:0019216),0.5157390406396375,1.2939616152300768,0.13021363173957273,0.7930368557844815,1.0,7/20,16.91%,NCOA1;NCOR1;CHD9;CREBBP;TBL1X;SREBF2;NCOA2
15,heart development (GO:0007507),0.5335089723459009,1.3006352274332074,0.1444906444906445,0.8027808076551227,1.0,9/16,28.31%,NIPBL;MEF2A;CHD7;SOX4;KDM6A;TCF25;NOTCH1;KAT2B;KDM6B
19,protein-DNA complex assembly (GO:0065004),0.5133203548000098,1.283920623932852,0.14681724845995894,0.7253443731046052,1.0,5/18,21.57%,TCF4;ATRX;PSME4;KAT6B;RSF1
20,regulation of macromolecule metabolic process (GO:0060255),0.5152146082166031,1.28175520615509,0.15408479834539815,0.700069293688372,1.0,9/18,28.31%,FOXP1;PEG3;APP;KDM6A;HMG20A;AFF1;HIF1A;PRDM2;KDM6B
17,regulation of Notch signaling pathway (GO:0008593),0.5395180480353707,1.2936809914302352,0.15513626834381553,0.7504914369239216,1.0,11/15,34.56%,MAML3;STAT3;CREBBP;SREBF2;MAML2;ZMIZ1;NOTCH1;RBPJ;KAT2B;EP300;EGFR
22,positive regulation of cytokine production (GO:0001819),0.502898137065746,1.25924992614198,0.15517241379310345,0.7421537254377845,1.0,9/22,25.74%,RUNX1;FOXP1;STAT3;CREBBP;APP;NFKB1;ARNT;LRRFIP1;HIF1A
18,generation of neurons (GO:0048699),0.5294104250635436,1.2875196733681766,0.15647668393782382,0.7432518180351346,1.0,2/16,1.35%,RUNX1;NAV1
30,negative regulation of apoptotic process (GO:0043066),0.4613030722679694,1.2197798006484089,0.16016016016016016,0.7014583661533024,1.0,12/34,22.79%,PAX7;GSK3B;FOXO1;BABAM2;MTDH;SFPQ;SIX1;PTMA;NFKB1;PIK3CA;RB1;NOTCH1
24,gene expression (GO:0010467),0.4994671587071555,1.2523124483275125,0.16396761133603238,0.7122186139137476,1.0,10/20,30.39%,RBM39;MEF2A;ATXN1;DDX17;TPR;HNRNPU;PTMA;BAZ2A;YTHDC1;EPC1
32,chromatin remodeling (GO:0006338),0.4335255212074356,1.1915856895412025,0.179,0.774238330151962,1.0,24/51,29.41%,ATRX;JARID2;TOP1;ARID1B;CHD4;PBRM1;HDAC4;ACTB;KDM5B;BPTF;KDM5A;KDM6A;GATAD2B;RB1;RSF1;KDM4C;BAZ2A;SMARCC1;EZH1;KAT2B;KDM5C;KDM6B;ESR1;CHD8
27,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.4896521768488167,1.22909494711784,0.18415637860082304,0.7354256013617921,1.0,5/18,15.81%,TCF7L2;PSME4;GSK3B;WWTR1;MLLT3
28,negative regulation of programmed cell death (GO:0043069),0.48621267001689605,1.2273927551618804,0.19576185671039353,0.7170186690784112,1.0,7/22,17.89%,PAX7;GSK3B;FOXO1;BABAM2;MTDH;PTMA;NFKB1
34,positive regulation of intracellular signal transduction (GO:1902533),0.45402738000272536,1.1728033793779762,0.24169184290030213,0.811999730852454,1.0,13/25,35.29%,TCF7L2;ANKRD17;APP;NFAT5;BRD4;MTDH;PIK3CA;BCLAF1;MIER1;ESR1;EP300;EGFR;DHX36
37,phosphorylation (GO:0016310),0.4341426525329747,1.1650167809376197,0.24549098196392785,0.7799952420777768,1.0,11/31,21.20%,STAT3;TOP1;CDK8;GSK3B;APP;CDK17;PIK3CA;DYRK1A;TLK2;HIPK2;CDK19
33,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.4988714237068422,1.1914989116122015,0.25773195876288657,0.7519706759721169,1.0,4/15,6.74%,TEAD1;NFIB;STAT3;DDX5
38,negative regulation of macromolecule metabolic process (GO:0010605),0.4514285325131749,1.1587201993329752,0.26310483870967744,0.7846555993510553,1.0,9/22,29.17%,RUNX1;FOXP1;APP;NFKB1;RB1;NOTCH1;MECP2;HIF1A;ESR1
35,positive regulation of Wnt signaling pathway (GO:0030177),0.47787969808461583,1.170864011717954,0.28186528497409324,0.7976211790262708,1.0,6/15,23.65%,ZEB2;PSME4;TBL1X;SOX4;NFKB1;TBL1XR1
45,regulation of cell population proliferation (GO:0042127),0.3906184641506456,1.0977514035995521,0.29,0.8973608091712593,1.0,29/69,35.05%,RUNX1;RBFOX2;STAT3;TCF7L2;LMNA;PBRM1;MEIS2;HDAC4;WWTR1;APP;ARID2;SOX4;ZBTB7C;SIX1;BRD7;NOTCH1;STAT5B;KDM4C;CCAR1;MECP2;PIAS1;KAT2B;SRPK2;HP1BP3;SKI;JUN;EGFR;MEIS1;SIRT2
39,regulation of autophagy (GO:0010506),0.4612509005447879,1.1438990223585053,0.2926078028747433,0.8262826710296901,1.0,10/19,35.05%,STAT3;GSK3B;FOXO1;SREBF2;MTDH;TLK2;FOXO3;ATF6;EP300;SIRT2
43,chromatin organization (GO:0006325),0.40180084228822466,1.1082825526854914,0.294,0.8944111533541117,1.0,27/58,31.99%,ATRX;SETD5;JARID2;TOP1;PBRM1;HDAC4;KDM5B;BPTF;KDM5A;HDAC8;KDM6A;HMG20A;RB1;TCF7L1;RSF1;SETD2;KDM4C;BAZ2A;SMARCC1;EZH1;KAT2B;KDM5C;EHMT1;KDM6B;ESR1;SMARCA5;HP1BP3
40,cellular response to hormone stimulus (GO:0032870),0.46830876727321824,1.1423945709574865,0.3141091658084449,0.8126453509756845,1.0,6/17,23.16%,NCOA1;STAT3;BCAS3;NCOA2;NR3C1;STAT5B
42,positive regulation of cell differentiation (GO:0045597),0.42291535055030316,1.1091392339696542,0.31955645161290325,0.9112023661484423,1.0,7/31,17.89%,TCF4;ZEB1;MEF2A;WWTR1;ZHX3;ASXL2;NFKB1
41,positive regulation of multicellular organismal process (GO:0051240),0.4272526986714328,1.1227412614364587,0.32028112449799195,0.874138501595801,1.0,14/31,29.53%,GNAS;RREB1;WWTR1;OGT;THRA;RFX3;SIX1;KDM3A;KDM1A;NR2C2;ENO1;EHMT1;KDM6B;BCL9L
50,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.3794232423759389,1.0631638234742722,0.332,0.9439192387003802,1.0,40/100,32.72%,FOXN3;ATRX;JMJD1C;RREB1;STAT3;ATXN1;ZFHX3;ANKRD17;CREBBP;WWTR1;NSD3;CHD7;APP;SOX4;NSD1;SFPQ;RFX3;SIX1;NCOA2;KAT6B;HMG20A;FUS;RB1;TCF7L1;NR3C1;NOTCH1;CCAR1;CLOCK;BAZ2A;HIF1A;NR2C2;SBNO2;PRDM2;FOXO3;SBNO1;ESR1;EP300;ZBTB38;HP1BP3;IRF2
44,regulation of protein phosphorylation (GO:0001932),0.4596681089350274,1.1027998504021361,0.35669456066945604,0.8969604821361186,1.0,4/15,13.85%,WWTR1;APP;BRD4;NSD1
47,negative regulation of gene expression (GO:0010629),0.39987103956441067,1.0871045384604805,0.35835835835835833,0.9031730390496101,1.0,16/42,30.51%,RUNX1;NCOR1;FOXP1;JARID2;CNOT1;APP;NFKB1;RB1;NOTCH1;NCL;MECP2;HIF1A;KAT2B;ESR1;EPC1;NCOR2
46,"positive regulation of gene expression, epigenetic (GO:0045815)",0.44173745466009584,1.0907793782234212,0.3779608650875386,0.9066670604921165,1.0,9/17,36.76%,ARID1B;ACTB;ATAD2B;SF3B1;ZMIZ1;KAT2B;EP300;SMARCA5;ARID1A
49,positive regulation of cell population proliferation (GO:0008284),0.39543581327066873,1.0650521533702224,0.387,0.955579464042242,1.0,17/37,34.80%,FOXP1;TCF7L2;MEIS2;HDAC4;WWTR1;SOX4;HNRNPU;KDM1A;NOTCH1;KDM4C;CCAR1;MECP2;RBPJ;SRPK2;LAMC1;EGFR;MEIS1
48,cellular component assembly (GO:0022607),0.44470227664354145,1.0826678711486124,0.38883143743536713,0.902516816240862,1.0,13/15,52.57%,TEAD1;CREBBP;ACTB;VMP1;KMT2A;LAMC1;ADD1;RAD21;HES1;PEX14;MITF;RBBP4;YAP1
51,transcription initiation from RNA polymerase II promoter (GO:0006367),0.3902070362596873,1.05710112141384,0.394,0.9504659548785581,1.0,17/46,30.51%,TEAD1;NCOR1;MAML3;CREBBP;WWTR1;TBL1X;THRA;NR6A1;MAML2;NR3C1;NOTCH1;TBL1XR1;RBPJ;NR2C2;KAT2B;ESR1;NCOR2
52,regulation of cell cycle (GO:0051726),0.405731628942515,1.052419179471895,0.4102306920762287,0.9502413585741346,1.0,14/29,35.05%,STAT3;TCF7L2;TTC28;ANKRD17;HNRNPU;RB1;HIPK2;NOTCH1;KAT2B;SRPK2;EP300;JUN;SMAD3;SIRT2
57,regulation of nucleic acid-templated transcription (GO:1903506),0.36623863276107993,1.0254027914077406,0.427,0.9652602241976262,1.0,38/98,32.72%,FOXN3;ATRX;JMJD1C;RREB1;STAT3;ATXN1;ZFHX3;CREBBP;WWTR1;NSD3;CHD7;SOX4;NSD1;SFPQ;RFX3;SIX1;NCOA2;KAT6B;HMG20A;FUS;ZMIZ1;RB1;TCF7L1;NR3C1;NOTCH1;CCAR1;CLOCK;BAZ2A;HIF1A;NR2C2;SBNO2;PRDM2;SBNO1;ESR1;EP300;ZBTB38;HP1BP3;IRF2
54,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.41702958049384514,1.0436810196918056,0.428863868986694,0.948606919989453,1.0,6/18,21.81%,RBFOX2;DDX5;DDX17;ZMIZ1;KDM3A;NR3C1
56,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.3570592781339295,1.026467628153506,0.43,0.978144436427592,1.0,60/141,37.01%,ZEB1;RBFOX2;FOXN3;NIPBL;NCOR1;ARID5B;FOXP1;ATXN1;TCF7L2;JARID2;GSK3B;CNOT1;HDAC4;TSHZ3;ZHX3;FOXO1;UIMC1;MBTD1;CBX5;THRA;SFPQ;RFX3;ZHX2;KAT6B;RB1;PBXIP1;ZMYND11;RSF1;NR3C1;BRD7;KDM1A;NOTCH1;NCL;MECP2;BCLAF1;CLOCK;SCMH1;RCOR1;POU2F1;RBPJ;ENO1;SBNO2;KDM5C;EHMT1;GLIS2;CHD8;PHC3;RUNX2;EPC1;NCOR2;ZBTB38;CBFA2T2;TRIM33;JUN;SIRT2;DHX36;ARID4A;SMARCC2;TFDP2;KAT6A
53,cytokine-mediated signaling pathway (GO:0019221),0.40099539751648877,1.0504700630308341,0.43417085427135677,0.9399065145117352,1.0,10/30,27.57%,ZEB1;STAT3;PSME4;FOXO1;NFKB1;PIK3CA;STAT5B;POU2F1;HIF1A;FOXO3
59,regulation of gene expression (GO:0010468),0.3567866724129681,1.0192968732594891,0.44,0.9546755139085144,1.0,56/141,35.29%,RUNX1;FOXN3;ATRX;FOXP1;JMJD1C;RREB1;STAT3;ATXN1;PEG3;ZFHX3;GSK3B;HDAC4;CREBBP;WWTR1;NSD3;CHD7;APP;SOX4;NSD1;SFPQ;RFX3;KDM6A;SIX1;NCOA2;KAT6B;HMG20A;NFKB1;FUS;RB1;ADAM19;AFF1;TCF7L1;NR3C1;NOTCH1;CCAR1;MECP2;CLOCK;BAZ2A;RBPJ;HIF1A;NR2C2;SBNO2;PRDM2;SBNO1;KDM6B;SRPK2;ESR1;YTHDC1;EP300;ZBTB38;HP1BP3;IRF2;ATF2;SMAD3;CHD3;DHX36
58,transcription by RNA polymerase II (GO:0006366),0.36454091024738067,1.0198987245981277,0.44,0.9688743828258897,1.0,24/81,26.35%,NFIX;TEAD1;NCOR1;MAML3;RREB1;DDX5;CREBBP;WWTR1;TBL1X;THRA;NR6A1;MLLT3;MAML2;NFKB1;NFIC;PRRX1;NR3C1;SETD2;NOTCH1;TBL1XR1;POU2F1;RBPJ;NR2C2;KAT2B
60,negative regulation of multicellular organismal process (GO:0051241),0.40950347089330946,1.0168568674396987,0.4754601226993865,0.9477346157977805,1.0,6/17,25.61%,NFIB;GSK3B;RB1;NOTCH1;KLF7;RBPJ
55,"mRNA splicing, via spliceosome (GO:0000398)",0.40501243372025,1.0292708166133329,0.4762386248736097,0.984954002920487,1.0,9/22,29.78%,DDX5;DDX17;SFPQ;SF3B1;HNRNPU;FUS;CCAR1;SRPK2;YTHDC1
62,ATP-dependent chromatin remodeling (GO:0043044),0.39658027488770153,1.0053553428187652,0.4807692307692308,0.9562765089674531,1.0,15/23,45.59%,ARID1B;CHD4;PBRM1;ACTB;GATAD2B;SMARCC1;CHD8;SMARCA5;CHD3;SMARCC2;ARID1A;INO80;MBD2;SMARCA4;SMARCA2
61,negative regulation of nucleic acid-templated transcription (GO:1903507),0.35157980981442005,1.0079076557134805,0.491,0.962887378925968,1.0,47/133,30.51%,ZEB1;RBFOX2;FOXN3;NIPBL;NCOR1;ARID5B;FOXP1;ATXN1;TCF7L2;JARID2;HDAC4;TSHZ3;ZHX3;FOXO1;UIMC1;MBTD1;CBX5;THRA;SFPQ;RFX3;ZHX2;KAT6B;RB1;PBXIP1;ZMYND11;RSF1;NR3C1;BRD7;KDM1A;NOTCH1;MECP2;BCLAF1;CLOCK;SCMH1;RCOR1;POU2F1;RBPJ;ENO1;SBNO2;KDM5C;EHMT1;GLIS2;CHD8;PHC3;RUNX2;EPC1;NCOR2
63,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.4058415932929432,0.9987863863598478,0.49691358024691357,0.9641907232041778,1.0,13/17,50.37%,ZEB2;CREBBP;HIPK2;BCL9L;EP300;SKI;TRIM33;SMAD3;ZBTB7A;SMAD4;CDKN1C;SNW1;SMAD2
64,regulation of cell migration (GO:0030334),0.39778931378517834,0.9907935854765493,0.5087538619979403,0.9750563970351273,1.0,7/18,27.57%,STAT3;LMNA;ZMYND8;ARID2;NOTCH1;CCAR1;FOXO3
66,positive regulation of DNA metabolic process (GO:0051054),0.3971685670836007,0.9658879108495885,0.5496894409937888,1.0,1.0,8/17,35.29%,ATRX;EYA4;BABAM2;UIMC1;MECP2;EYA1;EGFR;DHX36
67,positive regulation of response to DNA damage stimulus (GO:2001022),0.39888106444415794,0.9596501781439389,0.5535900104058272,1.0,1.0,4/15,13.36%,EYA4;DDX5;BABAM2;UIMC1
68,cellular response to growth factor stimulus (GO:0071363),0.38769144190066834,0.9557752966954337,0.5565939771547248,1.0,1.0,13/17,53.68%,WWOX;NR3C1;NOTCH1;STAT5B;RUNX2;EGFR;SMAD3;SIRT2;SMAD4;URI1;CTNNB1;SETX;MED1
65,histone modification (GO:0016570),0.3573993682375327,0.971739362041696,0.5665665665665666,1.0,1.0,30/40,55.64%,EYA4;HDAC4;CREBBP;NSD3;TBL1X;NSD1;KAT6B;PHF20;TBL1XR1;RCOR1;BAZ2A;MIER1;EHMT1;EYA1;EP300;MORF4L1;SIRT2;KAT6A;USP3;PRDM5;EYA3;TRRAP;RCOR3;EZH2;MORF4L2;ATXN7;BRD8;NAA50;BAZ1B;TRERF1
72,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.38667733110803415,0.9472324376089225,0.5682051282051283,0.9892308801627666,1.0,7/17,35.29%,ANKRD17;BRD4;MTDH;ZMYND11;MIER1;ESR1;DHX36
71,protein deubiquitination (GO:0016579),0.3618984894605499,0.9506796957697932,0.5778894472361809,0.9940791146882028,1.0,20/34,45.22%,MBD5;PSME4;ACTB;OGT;BABAM2;UIMC1;ASXL2;HIF1A;KAT2B;ESR1;ASXL1;EP300;INO80D;SMAD3;USP3;SMAD1;MYSM1;INO80;SMAD4;TRRAP
70,protein modification by small protein removal (GO:0070646),0.36128519478660537,0.9511644766060555,0.5793172690763052,1.0,1.0,20/34,45.22%,MBD5;PSME4;ACTB;OGT;BABAM2;UIMC1;ASXL2;HIF1A;KAT2B;ESR1;ASXL1;EP300;INO80D;SMAD3;USP3;SMAD1;MYSM1;INO80;SMAD4;TRRAP
69,"DNA-templated transcription, initiation (GO:0006352)",0.348618106234118,0.9526471143766865,0.585,1.0,1.0,19/55,31.50%,TEAD1;NCOR1;MAML3;CREBBP;WWTR1;TBL1X;THRA;NR6A1;MAML2;RSF1;NR3C1;NOTCH1;TBL1XR1;RBPJ;NR2C2;KAT2B;ESR1;NCOR2;SMARCA5
73,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.359852714441213,0.9450587083746768,0.5869346733668341,0.9820751116271581,1.0,20/31,50.49%,ARID5B;STAT3;HDAC4;APP;MTDH;NFKB1;HIPK2;KDM1A;CLOCK;ESR1;EP300;ATF2;SMAD3;ZBTB7A;SMARCA4;CTNNB1;DHX9;JUP;JMY;MBTPS2
76,protein phosphorylation (GO:0006468),0.34245134364794994,0.9310990205581481,0.5937813440320963,0.9787301537220969,1.0,9/31,21.20%,TOP1;CDK8;GSK3B;APP;CDK17;DYRK1A;TLK2;HIPK2;CDK19
75,regulation of phosphorylation (GO:0042325),0.38951130373368487,0.934951068720797,0.5950155763239875,0.9815932776734717,1.0,9/15,44.85%,OGT;APP;TPR;HIF1A;EP300;EGFR;SIRT2;ZBTB7A;CDKN1C
74,positive regulation of cellular process (GO:0048522),0.3491991172890956,0.93984163097099,0.6166166166166166,0.9824224144817119,1.0,17/40,35.29%,ZFHX3;LMNA;ANKRD17;MEIS2;HDAC4;WWTR1;SOX4;NOTCH1;KDM4C;CCAR1;MECP2;BCLAF1;SRPK2;EGFR;MEIS1;SIRT2;DHX36
77,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.35378888598456526,0.8999646740850222,0.6341212744090442,1.0,1.0,6/20,24.63%,PSME4;TBL1X;UBR2;RB1;TBL1XR1;CLOCK
79,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.3538395171653586,0.8959205375275004,0.6344195519348269,1.0,1.0,9/21,34.07%,TCF7L2;CDK8;THRA;NFKB1;MED13;MECP2;BCLAF1;RUNX2;JUN
80,histone deacetylation (GO:0016575),0.34414455652960985,0.8940245860127994,0.6459183673469387,1.0,1.0,10/23,35.05%,HDAC4;TBL1X;HDAC8;SFPQ;TBL1XR1;RCOR1;BAZ2A;MIER1;MORF4L1;SIRT2
78,negative regulation of cell differentiation (GO:0045596),0.34210313220505106,0.8974159473199538,0.6488933601609658,1.0,1.0,12/28,35.05%,MEIS2;WWTR1;FOXO1;HNRNPU;RB1;NOTCH1;ASXL1;SKI;EGFR;MEIS1;SMAD3;SIRT2
84,regulation of translation (GO:0006417),0.3621136892610698,0.8770473132653603,0.6561844863731656,1.0,1.0,5/15,27.57%,CNOT1;APP;SOX4;NCL;FOXO3
81,protein-containing complex assembly (GO:0065003),0.33578989885791555,0.8827008789538363,0.6676767676767676,1.0,1.0,16/28,47.18%,TEAD1;TCF7L2;GSK3B;CREBBP;KMT2A;TCF7L1;BCL9L;LAMC1;EP300;HES1;SMARCA4;PEX14;TRRAP;MITF;CTNNB1;DHX9
83,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.3559586595692511,0.8810259795582723,0.6717791411042945,1.0,1.0,7/19,29.78%,DDX5;SFPQ;SF3B1;HNRNPU;FUS;CCAR1;YTHDC1
85,chromosome organization (GO:0051276),0.3514902179962147,0.8758602832007727,0.676829268292683,0.9958495164334975,1.0,13/20,48.90%,TCF7L2;HDAC8;HMG20A;TCF7L1;EZH1;TOP2B;EHMT1;ZBTB7A;NUCKS1;SMARCA4;MTF2;SAFB;EZH2
87,cellular macromolecule biosynthetic process (GO:0034645),0.35472445998168783,0.8688887666033914,0.6776180698151951,0.9870897176730242,1.0,5/17,30.39%,MEF2A;TOP1;PTMA;BAZ2A;EPC1
88,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.34925733911633605,0.8655845168227377,0.684156378600823,0.9821155222597103,1.0,6/17,29.17%,TCF7L2;HDAC4;RB1;KDM1A;GLIS2;ESR1
91,protein deacetylation (GO:0006476),0.33864273280009316,0.8532119304197943,0.6865979381443299,0.9731563046657836,1.0,9/18,39.95%,HDAC4;TBL1X;TBL1XR1;RCOR1;BAZ2A;MIER1;MORF4L1;SIRT2;PRDM5
86,cellular response to oxygen-containing compound (GO:1901701),0.34181778387239553,0.874116936734711,0.6955645161290323,0.9881805339593687,1.0,11/24,36.27%,ACTB;FOXO1;NFKB1;SBNO2;LCOR;ESR1;NRIP1;JUN;EGFR;DHX36;CREB1
93,regulation of programmed cell death (GO:0043067),-0.18185015529501475,-0.8437467595558642,0.696969696969697,0.7160867372667675,0.875,15/16,60.78%,BIRC2;JAK2;MAGED1;ACTN2;ASAH1;SOX9;TRIM24;ANP32B;RARG;CHM;WRN;BCL6;ACTN1;ACTN4;ZBTB7A
94,cellular response to transforming growth factor beta stimulus (GO:0071560),0.34591050632592274,0.840201328326085,0.7125,0.9741683909716219,1.0,8/15,43.38%,WWOX;ZMIZ1;NR3C1;SKI;JUN;SMAD3;SMAD1;SMAD4
90,nucleosome organization (GO:0034728),0.33737939504922765,0.8606243205107398,0.7151515151515152,0.9699692541607313,1.0,12/24,43.63%,ATRX;ARID2;BPTF;KAT6B;RSF1;SETD2;SMARCC1;SMARCA5;SMARCC2;ARID1A;INO80;SMARCA4
95,regulation of DNA repair (GO:0006282),0.3475670916166442,0.8357403899191405,0.7244582043343654,0.9707904457094546,1.0,9/15,49.75%,EYA4;BABAM2;UIMC1;EYA1;EGFR;EYA3;DHX9;SMCHD1;PARG
89,cellular protein modification process (GO:0006464),0.31410505487246076,0.8641331913390718,0.729,0.974182690586171,1.0,16/39,37.38%,PSME4;CDK8;GSK3B;APP;DCAF6;CDK17;DYRK1A;TLK2;HIPK2;CDK19;HIF1A;SRPK2;LAMC1;SIRT2;CREB1;CCNT1
92,histone acetylation (GO:0016573),0.3375337687893677,0.8451460413577414,0.7324516785350966,0.9766758975745078,1.0,15/21,52.94%,CREBBP;KAT6B;PHF20;KAT2B;EPC1;EP300;MORF4L1;ATF2;BRD1;KAT6A;EP400;TRRAP;MORF4L2;BRD8;NAA50
82,positive regulation of gene expression (GO:0010628),0.3237491876544068,0.8826464380039777,0.7347347347347347,1.0,1.0,20/50,35.29%,STAT3;DDX5;GSK3B;ACTB;APP;SOX4;SF3B1;DYRK1A;ADAM19;NOTCH1;RBPJ;HIF1A;KAT2B;SRPK2;EP300;SMARCA5;ATF2;EGFR;SMAD3;DHX36
96,histone H4 acetylation (GO:0043967),0.323561872600262,0.8118412349270462,0.746938775510204,0.9965609170612393,1.0,13/20,52.45%,KANSL1;OGT;KMT2A;PHF20;EPC1;EP300;MORF4L1;ATF2;EP400;TRRAP;MSL1;MORF4L2;BRD8
98,positive regulation of apoptotic process (GO:0043065),0.30120681900508484,0.7689232696492293,0.795131845841785,1.0,1.0,9/22,35.05%,FOXO1;SOX4;CCAR1;BCLAF1;FOXO3;SRPK2;ATF6;JUN;SIRT2
100,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.30995418300548794,0.7644102826603988,0.801025641025641,1.0,1.0,7/18,35.29%,TCF7L2;CDK8;NFKB1;MED13;MECP2;RUNX2;DHX36
104,cellular response to organic cyclic compound (GO:0071407),0.30122592114965824,0.7361834784082083,0.8218331616889805,1.0,1.0,11/16,56.74%,ACTB;NR3C1;LCOR;ESR1;NRIP1;EGFR;URI1;CTNNB1;JUP;MED1;TAF1
99,"regulation of gene expression, epigenetic (GO:0040029)",0.2909227248031934,0.7663534698619475,0.8222222222222222,1.0,1.0,9/28,31.50%,JARID2;HDAC4;ACTB;SF3B1;MECP2;KAT2B;EPC1;EP300;SMARCA5
103,cellular response to lipid (GO:0071396),0.29929604947764693,0.7467878475925521,0.8279022403258656,1.0,1.0,13/20,53.68%,NFKB1;NR3C1;SBNO2;LCOR;ESR1;NRIP1;EGFR;CREB1;URI1;SNW1;SETX;HMGB1;MED1
109,proteasomal protein catabolic process (GO:0010498),0.28719804613611405,0.7144683931055428,0.8369453044375645,0.9827625249102542,1.0,4/17,24.63%,PSME4;TBL1X;TBL1XR1;CLOCK
97,"transcription, DNA-templated (GO:0006351)",0.28992957397032504,0.8002678505091803,0.843,1.0,1.0,19/54,38.85%,NFIX;RREB1;MEF2A;DDX5;THRA;MLLT3;PTMA;NFKB1;NFIC;RSF1;BAZ2A;FOXO3;EPC1;SMARCA5;CCNT2;NCOA6;CCNT1;TAF15;KLF13
110,positive regulation of programmed cell death (GO:0043068),0.28375515257790057,0.7054035195875626,0.8526100307062436,0.9814900536138049,1.0,11/19,51.10%,FOXO1;SOX4;CCAR1;BCLAF1;FOXO3;ATF6;JUN;CTNNB1;BCL6;JMY;HMGB1
101,negative regulation of cellular process (GO:0048523),0.2780271989663154,0.7633540262239878,0.8567134268537074,1.0,1.0,12/43,26.35%,LMNA;PBRM1;APP;ARID2;SOX4;ZBTB7C;UBR2;RB1;BRD7;NOTCH1;ENO1;KAT2B
108,DNA metabolic process (GO:0006259),0.2744112082524183,0.723336191416154,0.8610271903323263,0.9841052328430135,1.0,18/28,57.48%,TCF7L2;TOP1;PSME4;TOP2B;SRPK2;PURA;RAD21;USP3;SMC1A;INO80;KMT5B;TRRAP;PARG;HMGB1;BACH1;SMARCAD1;DOT1L;WRN
107,double-strand break repair (GO:0006302),0.2798830522126624,0.7251002946112762,0.8617558022199798,0.9916725224130479,1.0,17/25,57.48%,BABAM2;UIMC1;SFPQ;KDM2A;EYA1;SMARCA5;MORF4L1;RAD21;NUCKS1;EYA3;INO80;YY1;SETX;HMGB1;BAZ1B;SMARCAD1;WRN
102,cellular response to DNA damage stimulus (GO:0006974),0.2734115513779496,0.7484652825705704,0.8738738738738738,1.0,1.0,30/46,58.58%,NIPBL;FOXP1;PSME4;FOXO1;BABAM2;CBX5;TLK2;WAC;ZBTB38;ATF2;CBX1;NCOA6;USP3;RNF169;SMC1A;SHPRH;INO80;KMT5B;TRRAP;BCL6;YY1;SETX;BACH1;YAP1;SETD7;BAZ1B;DOT1L;TAF1;WRN;FMR1
106,negative regulation of cell population proliferation (GO:0008285),0.2674914621666249,0.7283029191975587,0.8847695390781564,0.9976611737536953,1.0,6/36,13.11%,LMNA;PBRM1;APP;ARID2;SOX4;ZBTB7C
113,negative regulation of G0 to G1 transition (GO:0070317),0.27005976681656524,0.6522660296727644,0.9003115264797508,0.9769323821195082,1.0,10/15,56.50%,CBX5;EHMT1;PHC3;EPC1;TFDP2;MGA;EZH2;RBBP4;SUZ12;YAF2
114,negative regulation of cell cycle process (GO:0010948),0.27005976681656524,0.6522660296727644,0.9003115264797508,0.9769323821195082,1.0,10/15,56.50%,CBX5;EHMT1;PHC3;EPC1;TFDP2;MGA;EZH2;RBBP4;SUZ12;YAF2
115,regulation of G0 to G1 transition (GO:0070316),0.27005976681656524,0.6522660296727644,0.9003115264797508,0.9769323821195082,1.0,10/15,56.50%,CBX5;EHMT1;PHC3;EPC1;TFDP2;MGA;EZH2;RBBP4;SUZ12;YAF2
111,positive regulation of macromolecule metabolic process (GO:0010604),0.264938471665136,0.701552580921341,0.9069069069069069,0.9759718815471313,1.0,21/36,53.68%,STAT3;GSK3B;APP;ADAM19;NOTCH1;RBPJ;HIF1A;SRPK2;RESF1;ATF2;SMAD3;DHX36;SMAD1;ATF7IP;SP1;MITF;NFE2L2;CALCOCO1;YAP1;CTCF;MED1
112,mRNA processing (GO:0006397),0.2640696665839172,0.6749504576360407,0.9076305220883534,0.9877803472711626,1.0,6/24,23.90%,DDX5;SFPQ;SF3B1;HNRNPU;FUS;CCAR1
105,regulation of apoptotic process (GO:0042981),0.26775748810141686,0.7287442618309714,0.914,1.0,1.0,13/50,28.68%,PAX7;GSK3B;CREBBP;FOXO1;BABAM2;SOX4;MTDH;PTMA;NFKB1;CCAR1;BCLAF1;FOXO3;ATF6
116,protein modification by small protein conjugation (GO:0032446),0.25077095385044296,0.63801132832136,0.9159067882472138,0.976679822413095,1.0,19/23,67.52%,TPR;PIAS2;UBR2;WAC;HIF1A;PIAS1;EYA1;TRIM33;SHPRH;PEX14;NFE2L2;NFX1;NUP98;RNF20;NUP153;CAND1;RLIM;SMURF1;UBE2L3
118,regulation of signal transduction by p53 class mediator (GO:1901796),0.23477889592199488,0.610276033389345,0.9414141414141414,0.9742738203331288,1.0,9/26,38.48%,CHD4;PHF20;HIPK2;BRD7;EHMT1;EP300;CHD3;KAT6A;TAF15
117,DNA repair (GO:0006281),0.22830053553223578,0.6135428743397613,0.9467336683417086,0.9813170982758727,1.0,20/34,57.48%,PSME4;BABAM2;UIMC1;SETD2;EYA1;SMARCA5;RAD21;USP3;NUCKS1;SMC1A;EYA3;INO80;SLC30A9;KMT5B;TRRAP;SETX;BACH1;BAZ1B;DOT1L;WRN
120,protein polyubiquitination (GO:0000209),0.22149278296560174,0.5469429332887168,0.9470954356846473,0.9845411526204307,1.0,12/16,67.52%,PSME4;UBR2;UBE3A;SHPRH;CTNNB1;CBFB;TAF1;RNF20;PSMC6;RLIM;SMURF1;UBE2L3
119,regulation of intracellular signal transduction (GO:1902531),0.21552173662626434,0.5685904720113565,0.9747729566094854,0.9849783588290916,1.0,10/30,38.48%,CHD4;PHF20;HIPK2;BRD7;EHMT1;EP300;EGFR;CHD3;KAT6A;TAF15
121,ubiquitin-dependent protein catabolic process (GO:0006511),0.17846140427198393,0.46410848557527373,0.9808467741935484,0.9967585320469626,1.0,4/24,24.63%,PSME4;TBL1X;TBL1XR1;CLOCK
122,protein ubiquitination (GO:0016567),0.17333334873605957,0.4522391293361953,0.9909274193548387,0.9905385193815744,1.0,19/28,67.52%,PSME4;UBR2;WAC;HIF1A;UBE3A;TRIM33;SHPRH;PEX14;CTNNB1;NFE2L2;CBFB;NFX1;TAF1;RNF20;PSMC6;CAND1;RLIM;SMURF1;UBE2L3
